Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images.

Bauckneht M, Lai R, Miceli A, Schenone D, Cossu V, Donegani MI, Raffa S, Borra A, Marra S, Campi C, Orengo A, Massone AM, Tagliafico A, Caponnetto C, Cabona C, Cistaro A, Chiò A, Morbelli S, Nobili F, Sambuceti G, Piana M, Marini C.

EJNMMI Res. 2020 Mar 23;10(1):23. doi: 10.1186/s13550-020-0607-5.

2.

Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant.

Barthel H, Arbizu J, Drzezga A, Garibotto V, Lammertsma AA, Morbelli S; EANM Neuroimaging Committee.

Eur J Nucl Med Mol Imaging. 2020 Mar 4. doi: 10.1007/s00259-020-04742-w. [Epub ahead of print] No abstract available.

PMID:
32130450
3.

A kinetics-based approach to amyloid PET semi-quantification.

Chincarini A, Peira E, Corosu M, Morbelli S, Bauckneht M, Capitanio S, Pardini M, Arnaldi D, Vellani C, D'Ambrosio D, Garibotto V, Assal F, Paghera B, Savelli G, Stefanelli A, Guerra UP, Nobili F.

Eur J Nucl Med Mol Imaging. 2020 Jan 25. doi: 10.1007/s00259-020-04689-y. [Epub ahead of print]

PMID:
31982991
4.

FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study.

Bauckneht M, Cossu V, Castellani P, Piccioli P, Orengo AM, Emionite L, Di Giulio F, Donegani MI, Miceli A, Raffa S, Borra A, Capitanio S, Morbelli S, Caviglia G, Bruno S, Ravera S, Maggi D, Sambuceti G, Marini C.

Mol Metab. 2020 Jan;31:98-108. doi: 10.1016/j.molmet.2019.11.007. Epub 2019 Nov 15.

5.

Metabolic network abnormalities in drug-naïve Parkinson's Disease.

Schindlbeck KA, Lucas-Jiménez O, Tang CC, Morbelli S, Arnaldi D, Pardini M, Pagani M, Ibarretxe-Bilbao N, Ojeda N, Nobili F, Eidelberg D.

Mov Disord. 2019 Dec 24. doi: 10.1002/mds.27960. [Epub ahead of print]

PMID:
31872507
6.

Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.

Bauckneht M, Capitanio S, Donegani MI, Zanardi E, Miceli A, Murialdo R, Raffa S, Tomasello L, Vitti M, Cavo A, Catalano F, Mencoboni M, Ceppi M, Marini C, Fornarini G, Boccardo F, Sambuceti G, Morbelli S.

Cancers (Basel). 2019 Dec 20;12(1). pii: E31. doi: 10.3390/cancers12010031.

7.

Metabolic correlates of dopaminergic loss in dementia with lewy bodies.

Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Vöglein J, Schnabel J, Unterrainer M, Perneczky R, Pogarell O, Buerger K, Catak C, Bartenstein P, Cumming P, Ewers M, Danek A, Levin J, Aarsland D, Nobili F, Rominger A, Brendel M.

Mov Disord. 2019 Dec 16. doi: 10.1002/mds.27945. [Epub ahead of print]

8.

Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab.

Rossi G, Bauckneht M, Genova C, Rijavec E, Biello F, Mennella S, Dal Bello MG, Cittadini G, Bruzzi P, Piva R, Ceriani V, Sambuceti G, Lopci E, Morbelli S, Grossi F.

J Nucl Med. 2019 Dec 5. pii: jnumed.119.233056. doi: 10.2967/jnumed.119.233056. [Epub ahead of print]

PMID:
31806768
9.

Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.

Meles SK, Renken RJ, Pagani M, Teune LK, Arnaldi D, Morbelli S, Nobili F, van Laar T, Obeso JA, Rodríguez-Oroz MC, Leenders KL.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):437-450. doi: 10.1007/s00259-019-04570-7. Epub 2019 Nov 25.

10.

Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients.

Boccardi M, Nicolosi V, Festari C, Bianchetti A, Cappa S, Chiasserini D, Falini A, Guerra UP, Nobili F, Padovani A, Sancesario G, Morbelli S, Parnetti L, Tiraboschi P, Muscio C, Perani D, Pizzini FB, Beltramello A, Salvini Porro G, Ciaccio M, Schillaci O, Trabucchi M, Tagliavini F, Frisoni GB.

Eur J Neurol. 2020 Mar;27(3):475-483. doi: 10.1111/ene.14117. Epub 2019 Dec 18.

PMID:
31692118
11.

Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.

Massa F, Farotti L, Eusebi P, Capello E, Dottorini ME, Tranfaglia C, Bauckneht M, Morbelli S, Nobili F, Parnetti L.

J Alzheimers Dis. 2019;72(4):1193-1207. doi: 10.3233/JAD-190539.

PMID:
31683477
12.

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.

Bauckneht M, Capitanio S, Raffa S, Roccatagliata L, Pardini M, Lapucci C, Marini C, Sambuceti G, Inglese M, Gallo P, Cecchin D, Nobili F, Morbelli S.

EJNMMI Radiopharm Chem. 2019 Apr 8;4(1):6. doi: 10.1186/s41181-019-0058-3. Review.

13.

Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution.

Massa F, Meli R, Morbelli S, Nobili F, Pardini M.

Ann Transl Med. 2019 Jul;7(Suppl 3):S133. doi: 10.21037/atm.2019.05.81. No abstract available.

14.

An H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma.

Monti E, Dono M, Gonella E, Spina B, Pitto F, Petrogalli F, Conte L, Ambrosetti E, Minuto MN, Ansaldo GL, Morbelli S, Zupo S, Giusti M.

Front Endocrinol (Lausanne). 2019 Jul 31;10:513. doi: 10.3389/fendo.2019.00513. eCollection 2019.

15.

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease.

Ramusino MC, Garibotto V, Bacchin R, Altomare D, Dodich A, Assal F, Mendes A, Costa A, Tinazzi M, Morbelli SD, Bauckneht M, Picco A, Dottorini ME, Tranfaglia C, Farotti L, Salvadori N, Moretti D, Savelli G, Tarallo A, Nobili F, Parapini M, Cavaliere C, Salvatore E, Salvatore M, Boccardi M, Frisoni GB.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):270-280. doi: 10.1007/s00259-019-04466-6. Epub 2019 Aug 6.

PMID:
31388720
16.

Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma.

Gay S, Monti E, Trambaiolo Antonelli C, Mora M, Spina B, Ansaldo G, Teliti M, Comina M, Conte L, Minuto M, Varaldo E, Zupo S, Massa B, Morbelli S, Giusti M.

Future Oncol. 2019 Aug;15(24s):13-19. doi: 10.2217/fon-2019-0099. Epub 2019 Aug 6.

17.

Dual-point FDG-PET/CT for treatment response assessment in Hodgkin lymphoma, when an FDG-avid lesion persists after treatment.

Borra A, Morbelli S, Zwarthoed C, Bianchi A, Bergesio F, Chauvie S, Zaucha JM, Taszner M, Malkowski B, Biggi A, Thyss A, Darcourt J, Gallamini A.

Am J Nucl Med Mol Imaging. 2019 Jun 15;9(3):176-184. eCollection 2019.

18.

Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis?

Lapucci C, Boffa G, Massa F, Franciotta D, Castelletti L, Uccelli A, Morbelli S, Nobili F, Benedetti L, Roccatagliata L.

Eur J Neurol. 2019 Oct;26(10):e86-e87. doi: 10.1111/ene.13977. Epub 2019 May 17. No abstract available.

PMID:
31099961
19.

Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Pilotto A, Schiano di Cola F, Premi E, Grasso R, Turrone R, Gipponi S, Scalvini A, Cottini E, Paghera B, Garibotto V, Rizzetti MC, Bonanni L, Borroni B, Morbelli S, Nobili F, Guerra UP, Perani D, Padovani A.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1642-1651. doi: 10.1007/s00259-019-04324-5. Epub 2019 May 16.

PMID:
31098748
20.

Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis.

Boffa G, Lapucci C, Morbelli SD, Nobili FM.

Q J Nucl Med Mol Imaging. 2019 Jun;63(2):225-226. doi: 10.23736/S1824-4785.19.03171-6. Epub 2019 May 8.

PMID:
31089076
21.

Comparison of visual criteria for amyloid-PET reading: could their merging reduce the inter-raters variability?

Paghera B, Altomare D, Peli A, Morbelli S, Buschiazzo A, Bauckneht M, Giubbini R, Rodella C, Camoni L, Boccardi M, Festari C, Muscio C, Padovani A, Frisoni GB, Guerra UP.

Q J Nucl Med Mol Imaging. 2019 May 8. doi: 10.23736/S1824-4785.19.03124-8. [Epub ahead of print]

PMID:
31089074
22.

Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC).

Chincarini A, Peira E, Morbelli S, Pardini M, Bauckneht M, Arbizu J, Castelo-Branco M, Büsing KA, de Mendonça A, Didic M, Dottorini M, Engelborghs S, Ferrarese C, Frisoni GB, Garibotto V, Guedj E, Hausner L, Hugon J, Verhaeghe J, Mecocci P, Musarra M, Queneau M, Riverol M, Santana I, Guerra UP, Nobili F.

Neuroimage Clin. 2019;23:101846. doi: 10.1016/j.nicl.2019.101846. Epub 2019 May 4.

23.

Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data.

Manzanera OM, Meles SK, Leenders KL, Renken RJ, Pagani M, Arnaldi D, Nobili F, Obeso J, Oroz MR, Morbelli S, Maurits NM.

Int J Neural Syst. 2019 Nov;29(9):1950010. doi: 10.1142/S0129065719500102. Epub 2019 Mar 3.

PMID:
31046514
24.

Mechanisms underlying resilience in ageing.

Stern Y, Chételat G, Habeck C, Arenaza-Urquijo EM, Vemuri P, Estanga A, Bartrés-Faz D, Cantillon M, Clouston SAP, Elman JA, Gold BT, Jones R, Kempermann G, Lim YY, van Loenhoud A, Martínez-Lage P, Morbelli S, Okonkwo O, Ossenkoppele R, Pettigrew C, Rosen AC, Scarmeas N, Soldan A, Udeh-Momoh C, Valenzuela M, Vuoksimaa E.

Nat Rev Neurosci. 2019 Apr;20(4):246. doi: 10.1038/s41583-019-0138-0. No abstract available.

PMID:
30814677
25.

G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells.

Scussolini M, Bauckneht M, Cossu V, Bruno S, Orengo AM, Piccioli P, Capitanio S, Yosifov N, Ravera S, Morbelli S, Piana M, Sambuceti G, Caviglia G, Marini C.

Sci Rep. 2019 Feb 26;9(1):2794. doi: 10.1038/s41598-019-38973-1.

26.

Metabolic patterns across core features in dementia with lewy bodies.

Morbelli S, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F.

Ann Neurol. 2019 May;85(5):715-725. doi: 10.1002/ana.25453. Epub 2019 Mar 22.

PMID:
30805951
27.

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.

Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A.

Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.

28.

Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.

Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BNM, Ossenkoppele R, Didic M, Guedj E, Arnaldi D, Massa F, Grazzini M, Pardini M, Mecocci P, Dottorini ME, Bauckneht M, Sambuceti G, Nobili F.

J Alzheimers Dis. 2019;68(1):383-394. doi: 10.3233/JAD-181022.

PMID:
30776000
29.

Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.

Arnaldi D, Meles SK, Giuliani A, Morbelli S, Renken RJ, Janzen A, Mayer G, Jonsson C, Oertel WH, Nobili F, Leenders KL, Pagani M; REMPET Study Group.

J Parkinsons Dis. 2019;9(1):229-239. doi: 10.3233/JPD-181468.

PMID:
30741687
30.

Increased myocardial 18F-FDG uptake as a marker of Doxorubicin-induced oxidative stress.

Bauckneht M, Pastorino F, Castellani P, Cossu V, Orengo AM, Piccioli P, Emionite L, Capitanio S, Yosifov N, Bruno S, Lazzarini E, Ponzoni M, Ameri P, Rubartelli A, Ravera S, Morbelli S, Sambuceti G, Marini C.

J Nucl Cardiol. 2019 Feb 8. doi: 10.1007/s12350-019-01618-x. [Epub ahead of print]

PMID:
30737636
31.

Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis.

Marini C, Morbelli S, Cistaro A, Campi C, Caponnetto C, Bauckneht M, Bellini A, Buschiazzo A, Calamia I, Beltrametti MC, Margotti S, Fania P, Poggi I, Cabona C, Capitanio S, Piva R, Calvo A, Moglia C, Canosa A, Massone A, Nobili F, Mancardi G, Chiò A, Piana M, Sambuceti G.

Brain. 2018 Aug 1;141(8):2272-2279. doi: 10.1093/brain/awy152.

32.

FDG-PET patterns associated with underlying pathology in corticobasal syndrome.

Pardini M, Huey ED, Spina S, Kreisl WC, Morbelli S, Wassermann EM, Nobili F, Ghetti B, Grafman J.

Neurology. 2019 Mar 5;92(10):e1121-e1135. doi: 10.1212/WNL.0000000000007038. Epub 2019 Jan 30.

33.

Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study.

Fiz F, Bauckneht M, Piccardo A, Campi C, Nieri A, Piva R, Ferrarazzo G, Artom N, Morbelli S, Marini C, Piana M, Bagnasco M, Canepa M, Sambuceti G.

Am J Nucl Med Mol Imaging. 2018 Dec 20;8(6):387-396. eCollection 2018.

34.

Obligatory role of endoplasmic reticulum in brain FDG uptake.

Cossu V, Marini C, Piccioli P, Rocchi A, Bruno S, Orengo AM, Emionite L, Bauckneht M, Grillo F, Capitanio S, Balza E, Yosifov N, Castellani P, Caviglia G, Panfoli I, Morbelli S, Ravera S, Benfenati F, Sambuceti G.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1184-1196. doi: 10.1007/s00259-018-4254-2. Epub 2019 Jan 8.

PMID:
30617965
35.

Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.

Massa F, Arnaldi D, De Cesari F, Girtler N, Brugnolo A, Grazzini M, Bauckneht M, Meli R, Morbelli S, Pardini M, Sambuceti G, De Carli F, Tiraboschi P, Nobili F.

Neurobiol Aging. 2019 Apr;76:9-17. doi: 10.1016/j.neurobiolaging.2018.12.001. Epub 2018 Dec 13.

PMID:
30611093
36.

A new frontier for amyloid PET imaging: multiple sclerosis.

Morbelli S, Bauckneht M, Capitanio S, Pardini M, Roccatagliata L, Nobili F.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):276-279. doi: 10.1007/s00259-018-4232-8. Epub 2018 Dec 15. No abstract available.

PMID:
30554257
37.

Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.

De Carli F, Nobili F, Pagani M, Bauckneht M, Massa F, Grazzini M, Jonsson C, Peira E, Morbelli S, Arnaldi D; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):334-347. doi: 10.1007/s00259-018-4197-7. Epub 2018 Oct 31.

PMID:
30382303
38.

An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline.

Sarocchi M, Bauckneht M, Arboscello E, Capitanio S, Marini C, Morbelli S, Miglino M, Congiu AG, Ghigliotti G, Balbi M, Brunelli C, Sambuceti G, Ameri P, Spallarossa P.

J Transl Med. 2018 Oct 25;16(1):295. doi: 10.1186/s12967-018-1670-9.

39.

Assessment of Skeletal Tumor Load in Metastasized Castration-Resistant Prostate Cancer Patients: A Review of Available Methods and an Overview on Future Perspectives.

Fiz F, Dittman H, Campi C, Morbelli S, Marini C, Brignone M, Bauckneht M, Piva R, Massone AM, Piana M, Sambuceti G, la Fougère C.

Bioengineering (Basel). 2018 Jul 28;5(3). pii: E58. doi: 10.3390/bioengineering5030058. Review.

40.

Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.

Marani C, Raiola AM, Morbelli S, Dominietto A, Ferrarazzo G, Avenoso D, Giannoni L, Varaldo R, Gualandi F, Grazia D, Lamparelli T, Bregante S, Van Lint MT, Ibatici A, Bovis F, Lemoli RM, Gobbi M, Bacigalupo A, Angelucci E.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2501-2508. doi: 10.1016/j.bbmt.2018.07.025. Epub 2018 Jul 21.

41.

Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study.

Buschiazzo A, Cossu V, Bauckneht M, Orengo A, Piccioli P, Emionite L, Bianchi G, Grillo F, Rocchi A, Di Giulio F, Fiz F, Raffaghello L, Nobili F, Bruno S, Caviglia G, Ravera S, Benfenati F, Piana M, Morbelli S, Sambuceti G, Marini C.

EJNMMI Res. 2018 Jun 11;8(1):44. doi: 10.1186/s13550-018-0398-0.

42.

Education-Adjusted Normality Thresholds for FDG-PET in the Diagnosis of Alzheimer Disease.

Mainta IC, Trombella S, Morbelli S, Frisoni GB, Garibotto V; Alzheimer Disease Neuroimaging Initiative (ADNI).

Neurodegener Dis. 2018;18(2-3):120-126. doi: 10.1159/000488915. Epub 2018 Jun 5.

PMID:
29870998
43.

Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis.

Bauckneht M, Chincarini A, De Carli F, Terzaghi M, Morbelli S, Nobili F, Arnaldi D.

Sleep Med Rev. 2018 Oct;41:266-274. doi: 10.1016/j.smrv.2018.04.001. Epub 2018 Apr 22. Review.

PMID:
29784534
44.

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.

Bouwman F, Orini S, Gandolfo F, Altomare D, Festari C, Agosta F, Arbizu J, Drzezga A, Nestor P, Nobili F, Walker Z, Morbelli S, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1526-1533. doi: 10.1007/s00259-018-4034-z. Epub 2018 May 9.

45.

Emerging topics and practical aspects for an appropriate use of amyloid PET in the current Italian context.

Nobili F, Cagnin A, Calcagni ML, Chincarini A, Guerra UP, Morbelli S, Padovani A, Paghera B, Pappatà S, Parnetti L, Sestini S, Schillaci O.

Q J Nucl Med Mol Imaging. 2019 Mar;63(1):83-92. doi: 10.23736/S1824-4785.18.03069-8. Epub 2018 Apr 24. Review.

PMID:
29697220
46.

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).

Bauckneht M, Chincarini A, Piva R, Arnaldi D, Girtler N, Massa F, Pardini M, Grazzini M, Efeturk H, Pagani M, Sambuceti G, Nobili F, Morbelli S.

Alzheimers Res Ther. 2018 Apr 3;10(1):35. doi: 10.1186/s13195-018-0366-y.

47.

Amyloid PET Imaging: Standardization and Integration with Other Alzheimer's Disease Biomarkers.

Morbelli S, Bauckneht M.

Methods Mol Biol. 2018;1750:203-212. doi: 10.1007/978-1-4939-7704-8_13.

PMID:
29512074
48.

The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.

Meles SK, Renken RJ, Janzen A, Vadasz D, Pagani M, Arnaldi D, Morbelli S, Nobili F, Mayer G, Leenders KL, Oertel WH; REMPET Study Group.

J Nucl Med. 2018 Sep;59(9):1437-1444. doi: 10.2967/jnumed.117.202242. Epub 2018 Feb 23.

49.

Reply: Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders?

Sambuceti G, Morbelli S, Cossu V, Marini C, Bauckneht M.

J Nucl Med. 2018 Apr;59(4):713-714. doi: 10.2967/jnumed.117.206797. Epub 2018 Jan 18. No abstract available.

50.

Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers.

Arnaldi D, De Carli F, Famà F, Brugnolo A, Girtler N, Picco A, Pardini M, Accardo J, Proietti L, Massa F, Bauckneht M, Morbelli S, Sambuceti G, Nobili F.

Mov Disord. 2017 Dec;32(12):1738-1747. doi: 10.1002/mds.27190. Epub 2017 Nov 9.

PMID:
29119593

Supplemental Content

Loading ...
Support Center